Profile
Pharma Nord ApS - a Scandinavian manufacturer with focus on medicine for cardiovascular diseases based on a Coenzyme Q10 API.
Pharma Nord actively supports science in its efforts to find new treatments or adjunctive therapies with a low risk factor.
More than 100 scientific studies have been carried out using Pharma Nord’s two CoQ10 preparations, Myoqinon and Bio-Quinone.
Myoqinon is registered as a medical drug in several EU countries.
The products have been used in numerous studies, including in the groundbreaking Q-Symbio study that is published in the Journal of the American College of Cardiology.
The products have been assigned an IND.
Additional Info
ACC.19 Learning Pathways? (select one)
Heart Failure and Cardiomyopathies